NEW ANTICANCER DRUGS FOR SOLID TUMORS IN THE LAST 10 YEARS: DIFFERENCES IN APPROVAL AND ACCESS BETWEEN THE UNITED STATES AND BRAZIL IN THE PUBLIC AND PRIVATE SECTORS. Authors: RAFAEL BALSINI BARRETO (CENTRO DE PESQUISAS ONCOLOGICAS – CEPON – FLORIANÓPOLIS – Santa Catarina – Brasil), ANDRESSA MORETTI IZIDORO (CENTRO DE PESQUISAS ONCOLOGICAS – CEPON – FLORIANÓPOLIS – Santa Catarina – Brasil), SAULO BRITO SILVA (FACULDADE DE MEDICINA DE RIBEIRÃO PRETO – UNIVERSIDADE DE SÃO PAULO – RIBEIRÃO PRETO – São Paulo – Brasil)